Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Evogene Ltd Ord (EVGN)

Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

REHOVOT, Israel , April 2, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ : EVGN)(TASE: EVGN) (the " Company ", " Evogene "), a pioneering company in computational chemistry, specializing...

EVGN : 0.7834 (-3.16%)
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock

Today, castor oil is a premium sustainable industrial feedstock for bio-based products

EVGN : 0.7834 (-3.16%)
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026

Conference will be held at Lisbon, Portugal - March 23–25, 2026

EVGN : 0.7834 (-3.16%)
Evogene: Q4 Earnings Snapshot

Evogene: Q4 Earnings Snapshot

EVGN : 0.7834 (-3.16%)
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results

Conference call and webcast: today, March 05, 2026, 9:00 AM ET

EVGN : 0.7834 (-3.16%)
Evogene Releases CEO Letter to Shareholders

Updating on Strategic Progress and Outlook

EVGN : 0.7834 (-3.16%)
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release

Zoom conference call scheduled for March 5, 2026, 9:00 AM ET

EVGN : 0.7834 (-3.16%)
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics

Aiming to introduce a new therapeutic strategy for overcoming chemotherapy resistance in lung cancer due to increased expression of cellular pathways

EVGN : 0.7834 (-3.16%)
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases

The collaboration is supported by a pan-European EUREKA grant, with participation of the Weizmann Institute of Science

EVGN : 0.7834 (-3.16%)
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds

REHOVOT, Israel and BOSTON , Feb. 10, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) ("Evogene" or the "Company"), a pioneering computational chemistry company, specializing in the...

EVGN : 0.7834 (-3.16%)

Barchart Exclusives

Why Bernstein Thinks You Should Buy the Dip in Sandisk Stock Here
TurboQuant has created an attractive entry point in Sandisk according to Bernstein analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.